Arjan Buijs

Research Analyst

Strategic program(s):

Strategic program(s):

Contact

Recent publications

Multilineage involvement in ABL-class fusion-positive pediatric B-cell acute lymphoblastic leukemia Inge Van Outersterp, Judith M Boer, Edwin Sonneveld, Anja X De Jong, Stefan Nierkens, Vincent H J Van der Velden, Arjan Buijs, Maaike Luesink, Monique L Den Boer, Peter M Hoogerbrugge
Haematologica, 2025, vol. 111, p.2528-2533
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics Judith M. Boer, Marco J. Koudijs, Lennart A. Kester, Edwin Sonneveld, Jayne Y. Hehir-Kwa, Simone Snijder, Esme Waanders, Arjan Buijs, Valérie De Haas, Inge M. Van Der Sluis, Rob Pieters, Monique L. Den Boer, Bastiaan B.J. Tops
JCO Precision Oncology, 2025, vol. 9
Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia Willem K Smits, Carlo Vermeulen, Rico Hagelaar, Shunsuke Kimura, Eric M Vroegindeweij, Jessica G C A M Buijs-Gladdines, Ellen van de Geer, Marjon J A M Verstegen, Erik Splinter, Simon V van Reijmersdal, Arjan Buijs, Niels Galjart, Winfried van Eyndhoven, Max van Min, Roland Kuiper, Patrick Kemmeren, Charles G Mullighan, Wouter de Laat, Jules P P Meijerink
Cell Reports, 2023, vol. 42
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma N. van Engelen, F. van Dijk, E. Waanders, A. Buijs, M. A. Vermeulen, J. L.C. Loeffen, R. P. Kuiper, M. C.J. Jongmans
Familial cancer, 2021, vol. 20, p.349-354
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS Eline J M Bertrums, C Michel Zwaan, Daisuke Hasegawa, Valerie De Haas, Dirk N Reinhardt, Franco Locatelli, Barbara De Moerloose, Michael Dworzak, Arjan Buijs, Petr Smisek, Alexandra Kolenova, Cornelis Jan Pronk, Jan-Henning Klusmann, Ana Carboné, Alina Ferster, Evangelia Antoniou, Soheil Meshinchi, Susana C Raimondi, Charlotte M Niemeyer, Henrik Hasle, Marry M Van den Heuvel-Eibrink, Bianca F Goemans
Haematologica, 2021, vol. 107, p.759-764
Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3’ MECOM Lars T. van der Veken, Merel C. Maiburg, Floris Groenendaal, Mariëlle E. van Gijn, Andries C. Bloem, Claudia Erpelinck, Stefan Gröschel, Mathijs A. Sanders, Ruud Delwel, Marc B. Bierings, Arjan Buijs
Haematologica, 2018, vol. 103, p.e173-e176